TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Clinical trial NCT04485013 · RECRUITING
Trial details
- NCT number
- NCT04485013
- Sponsor
- Tizona Therapeutics, Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2027-06-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.